Anti-IL-4Ra/TSLPBispecific Antibody

N/A

Report date: 2025/09/29 16:01:41

Base Information

Drug NameAnti-IL-4Ra/TSLPBispecific Antibody
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionInterleukin-4 receptor subunit alpha inhibitorsThymic stromal lymphopoietin inhibitors
TargetsInterleukin-4 receptor subunit alphaThymic stromal lymphopoietin
Therapy Area/IndicationsEczemaAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhuhai United Laboratories Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai United Laboratories Co Ltd
Inactive CompaniesN/A
Active IndicationsEczemaAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A